Upstream Bio

Upstream Bio is a biotech company aiming to develop therapies that get to the source of inflammation. 

Photo of Wall Street street sign with american flags in the background
Biotech

Upstream swells IPO to $255M as it lists alongside CAMP4

Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 this morning in becoming the latest biotechs to list on the Nasdaq.
James Waldron Oct 11, 2024 5:18am
IPO initial public offering wall street

CAMP4 is latest to eye IPO, while Upstream spells out $182M plan

Oct 7, 2024 8:44am
salmon river fish jump upstream katmai alaska

Inflammation-focused Upstream to join trickle of biotech IPOs

Sep 19, 2024 4:50am
parachute chutes

Lonza lands new CEO—Chutes & Ladders

Apr 5, 2024 8:30am
topic report
2022 money

Biotech's top money raisers: 2022

Apr 11, 2023 9:19am
success failure signposts

Samantha Truex returns to C-suite with $200M and new company

Jun 2, 2022 6:00am